分化型甲状腺癌肺转移的研究进展  

Research progress in pulmonary metastasis of differentiated thyroid cancer

作　　者：申江玉 晋建华[1] Shen Jiangyu;Jin Jianhua(Department of Nuclear Medicine,the First Hospital of Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学第一医院核医学科,太原030001

出　　处：《国际放射医学核医学杂志》2021年第10期663-668,共6页International Journal of Radiation Medicine and Nuclear Medicine

摘　　要：分化型甲状腺癌(DTC)的发病率呈逐年上升趋势, 当发生远处转移时患者的生存质量变差、生存率明显降低。肺是DTC最常见的远处转移部位, 占DTC远处转移的55%~85%。DTC肺转移是造成甲状腺癌患者病死的主要因素。故针对此类患者的早期诊断、评估以及治疗决策的制定尤为重要, 同时这也是缩短我国与发达国家甲状腺癌诊治的差距、提高患者生存质量的关键。笔者就近年来有关DTC肺转移的流行病学及临床病理特征、诊断与动态评估以及治疗方法等研究进展作一综述。The incidence of differentiated thyroid carcer(DTC)is increasing year by year.When distant metastasis occurs,the patients'life quality and survival rate were significantly reduced.Lung is the most common site,accounting for 55%-85%of distant metastasis with DTC,and is the main factor of death threat of thyroid cancer.Therefore,early diagnosis,evaluation and treatment decisions for these patients are particularly important,and it is also the key to shorten the gap between the diagnosis and treatment of thyroid cancer in China and developed countries and improve the quality of life of patients.This paper reviews the research progress in the epidemiological and clinic pathologic features,diagnosis,evaluation and treatment of pulmonary metastasis with DTC.

关 键 词：甲状腺肿瘤 肿瘤转移 肺转移 

分 类 号：R736.1[医药卫生—肿瘤]